Challenges in Endocrine Disruptor Toxicology and Risk Assessment
eBook - ePub

Challenges in Endocrine Disruptor Toxicology and Risk Assessment

  1. 518 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Challenges in Endocrine Disruptor Toxicology and Risk Assessment

About this book

Insight into the role of hormones, particularly estrogen and testosterone, in health and disease etiology โ€“ including interactions with other hormone pathways โ€“ has dramatically changed. Estrogen and androgen receptors, with their polymorphisms, are key molecules in all tissues and are involved in a number of homeostatic mechanisms but also pathological processes including carcinogenesis and the development of metabolic and neurological disorders such as diabetes and Alzheimer's disease. Endocrine disrupting chemicals (EDCs) can interfere with the endocrine (hormone) systems at certain dosages and play a key role in the pathology of disease. Most known EDCs are manmade and are therefore an increasing concern given the number commonly found in household products and the environment. This book will cover the mechanisms of EDC pathology across the spectrum of disease, as well as risk assessment and government and legal regulation to provide a holistic view of the current issues and cutting-edge research in the topic. With contributions from global leaders in the field, this book will be an ideal reference for toxicologists, endocrinologists and researchers interested in developmental biology, regulatory toxicology and the interface between environment and human health.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, weโ€™ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere โ€” even offline. Perfect for commutes or when youโ€™re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Challenges in Endocrine Disruptor Toxicology and Risk Assessment by Alberto Mantovani, Alexandra Fucic, Alberto Mantovani,Alexandra Fucic in PDF and/or ePUB format, as well as other popular books in Physical Sciences & Chemistry. We have over one million books available in our catalogue for you to explore.

Information

Table of contents

  1. Cover
  2. Half Title
  3. Title
  4. Copyright
  5. Preface
  6. Contents
  7. Section 1 โ€“ Endocrine Disruptor: Mechanisms and Effects
  8. Chapter 1 Endocrine Disruptor Effects on Estrogen, Androgen and Thyroid Pathways: Recent Advances on Screening and Assessment
  9. Chapter 2 Epigenetic Reprogramming by Endocrine Disrupting Chemicals
  10. Chapter 3 Issues for Hazard Characterization of Endocrine Disrupting Chemicals: The Use of Adverse Outcome Pathways
  11. Chapter 4 Integrated Translation Framework for Endocrine Disruptors in the area of Computational Toxicology
  12. Chapter 5 Sex-specific Actions of Endocrine Disruptors
  13. Chapter 6 Health Risks of Transplacental Exposure to Endocrine Disruptors
  14. Chapter 7 Endocrine Disruptors and Cancer: From Genotoxicity Mechanisms to Ethnicity-related Susceptibility
  15. Chapter 8 Bone as a Target for Endocrine Disruptors
  16. Chapter 9 Pathways of ED-induced Neuro-developmental Disturbances: An Overview
  17. Chapter 10 Vitamin A and the Retinoid System โ€“ From Nutrition to Endocrine Disruption
  18. Chapter 11 Linking Ecohealth and One Health approaches. A Case Study on the EU Water Framework Directive Strategy About Alkylphenols in Aquatic Ecosystems
  19. Chapter 12 Pollution of Water and Food by Hormonally Active Pesticides and Drugs (Human and Veterinary): Focus on Emerging Countries: Emerging Contaminants with Endocrine Disruption Potential in Brazil
  20. Chapter 13 Pollution of Food and Water by Hormonally Active Pesticides and Veterinary Drugs Residues: Focus on Sub Saharan African Countries
  21. Chapter 14 Natural Substances in Supplements and Nutraceuticals as Endocrine Disruptors
  22. Chapter 15 Endocrine Disruptors in Building Materials
  23. Chapter 16 Endocrine Disrupting Chemicals in Clothing and Cosmetics
  24. Chapter 17 Challenges in Endocrine Disruptor Toxicology and Risk Assessment
  25. Chapter 18 Biomarkers of Effect for EDCs and Indicators to be Used in Epidemiological Studies on Reproductive Health
  26. Chapter 19 Occupational Exposure to Endocrine Disruptors and Reproductive Health
  27. Chapter 20 Interdisciplinary Collaboration between Environmental Health and Clinical Experts on Cancers and Infertility Associated with Exposure to Endocrine Disruptors
  28. Chapter 21 Regulation and Risk Management of Endocrine Disruptors: Current Status and Future Perspectives
  29. Subject Index